Literature DB >> 33536931

Acacetin Ameliorates Experimental Colitis in Mice via Inhibiting Macrophage Inflammatory Response and Regulating the Composition of Gut Microbiota.

Junyu Ren1, Bei Yue1, Hao Wang1, Beibei Zhang1, Xiaoping Luo1, Zhilun Yu1, Jing Zhang1, Yijing Ren1, Sridhar Mani2, Zhengtao Wang1, Wei Dou1.   

Abstract

Acacetin, a natural dietary flavonoid abundantly found in acacia honey and citrus fruits, reportedly exerts several biological effects, such as anti-tumor, anti-inflammatory, and anti-oxidative effects. However, the effects of acacetin on intestinal inflammation remain unclear. We sought to investigate whether acacetin ameliorates inflammatory bowel disease (IBD) in mice with dextran sulfate sodium (DSS)-induced ulcerative colitis (UC). Our results suggest that acacetin alleviates the clinical symptoms of DSS-induced colitis, as determined by body weight loss, diarrhea, colon shortening, inflammatory infiltration, and histological injury. Further studies showed that acacetin remarkably inhibited both the macrophage inflammatory response in vitro and levels of inflammatory mediators in mice with colitis. In addition, some features of the gut microbiota were disordered in mice with DSS-induced colitis, as evidenced by a significant reduction in microbiota diversity and a marked shift in bacterial profiles. However, acacetin treatment improved this imbalance and restored gut microbiota to levels that were similar to those in normal mice. In conclusion, our work presents evidence that acacetin attenuates DSS-induced colitis in mice, at least in part, by inhibiting inflammation and regulating the intestinal microbiota.
Copyright © 2021 Ren, Yue, Wang, Zhang, Luo, Yu, Zhang, Ren, Mani, Wang and Dou.

Entities:  

Keywords:  acacetin; dextran sulfate sodium; gut microbiota; inflammatory mediators; ulcerative colitis

Year:  2021        PMID: 33536931      PMCID: PMC7848181          DOI: 10.3389/fphys.2020.577237

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  7 in total

1.  The Future of Physiology: 2020 and Beyond.

Authors:  Stephen Pandol
Journal:  Front Physiol       Date:  2021-04-12       Impact factor: 4.566

2.  Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis.

Authors:  Yi Wu; Xinqiao Liu; Guiwei Li
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

3.  Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis.

Authors:  Xiao Lin; Fang Xu; Ke-Wen Zhang; Wu-Xia Qiu; Hui Zhang; Qiang Hao; Meng Li; Xiao-Ni Deng; Ye Tian; Zhi-Hao Chen; Ai-Rong Qian
Journal:  Front Cell Dev Biol       Date:  2022-04-19

Review 4.  Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals.

Authors:  Liang Kang; Huaqing Zhang; Chongyu Jia; Renjie Zhang; Cailiang Shen
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

Review 5.  A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization.

Authors:  Zhihua Yang; Shanshan Lin; Wanying Feng; Yangxi Liu; Zhihui Song; Guiyun Pan; Yuhang Zhang; Xiangdong Dai; Xinya Ding; Lu Chen; Yi Wang
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

Review 6.  Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID).

Authors:  Marjo J E Campmans-Kuijpers; Gerard Dijkstra
Journal:  Nutrients       Date:  2021-03-25       Impact factor: 5.717

Review 7.  A Novel Pathway of Flavonoids Protecting against Inflammatory Bowel Disease: Modulating Enteroendocrine System.

Authors:  Mingrui Li; Benno Weigmann
Journal:  Metabolites       Date:  2022-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.